The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 18, 2019

Filed:

Mar. 27, 2017
Applicant:

Vision Global Holdings Ltd., Hong Kong, HK;

Inventors:

Bing Lou Wong, Irvine, CA (US);

Norman Fung Man Wai, Vancouver, CA;

Sui Yi Kwok, Hong Kong, HK;

Man Kin Wong, Hong Kong, HK;

Cornelia Wing Yin Man, Hong Kong, HK;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/00 (2006.01); A61M 36/14 (2006.01); A61K 45/06 (2006.01); A61K 38/42 (2006.01); A61K 49/00 (2006.01); A61K 51/08 (2006.01); A61K 47/64 (2017.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 38/42 (2013.01); A61K 47/6445 (2017.08); A61K 49/0043 (2013.01); A61K 49/0056 (2013.01); A61K 51/088 (2013.01);
Abstract

The present invention provides a pharmaceutical composition containing hemoglobin-based therapeutic agent for treating cancer. The hemoglobin moiety can target cancer cells and the therapeutic moiety (i.e. active agent/therapeutic drug) can kill the cancer cells efficiently. The hemoglobin-based therapeutic agent used in the present invention can be used in the treatment of various cancers such as pancreatic cancer, leukemia, head and neck cancer, colorectal cancer, lung cancer, breast cancer, liver cancer, nasopharyngeal cancer, esophageal cancer, prostate cancer, stomach cancer and brain cancer. The composition can be used alone or in combination with other therapeutic agent(s) such as chemotherapeutic agent to give a synergistic effect on cancer treatment, inhibiting metastasis and/or reducing recurrence. The presently claimed hemoglobin-based 5FU-two-dye conjugate and/or hemoglobin-based 5FU-one-dye conjugate can also be used in live-cell imaging and diagnostic imaging.


Find Patent Forward Citations

Loading…